3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Prostatic Neoplasms
17
Neoplasms
13
Breast Neoplasms
12
Neuroendocrine Tumors
8
Carcinoma, Non-Small-Cell Lung
8
Lung Neoplasms
7
Neoplasm Metastasis
6
Esophageal Neoplasms
5
Uterine Cervical Neoplasms
4
Stomach Neoplasms
4
Multiple Myeloma
4
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Mouth Neoplasms
3
Lymphoma, Non-Hodgkin
3
Glioma
3
Esophageal Squamous Cell Carcinoma
3
Urinary Bladder Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplastic Cells, Circulating
2
Nasopharyngeal Carcinoma
2
Multiple Pulmonary Nodules
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
Liver Neoplasms
2
Leukemia
2
Hypoxia
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Interventions
Cyclophosphamide
77
Dexamethasone
74
Melphalan
65
Lenalidomide
50
Bortezomib
50
Peripheral Blood Stem Cell Transplantation
49
fludarabine phosphate
47
Busulfan
46
Filgrastim
39
Tacrolimus
37
Antilymphocyte Serum
33
Radiotherapy
30
Mycophenolic Acid
30
Thalidomide
28
fludarabine
24
Methotrexate
22
Whole-Body Irradiation
21
Cyclosporine
21
Calcium Dobesilate
21
Granulocyte Colony-Stimulating Factor
18
Methylprednisolone
17
Etoposide
17
Cord Blood Stem Cell Transplantation
14
daratumumab
11
Prednisone
11
Carmustine
11
sargramostim
10
Stem Cell Transplantation
10
Sirolimus
10
Rituximab
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neoplasms, Plasma Cell
×
Positron Emission Tomography Computed Tomography
×
Clear all
NCT03314636
2025-08-08
CONPET
Oslo University Hospital
Phase 2
Active not recruiting
53 enrolled